Acta Med. 2008, 51: 31-35

The Expression of CD38 ADP-ribosyl Cyclase Ectoenzyme in Immune Cells of Cardiac Surgical Patients

Martina Koláčkováa, Manuela Trojáčková Kudlováa, Vladimír Lonskýb, Jiří Manďákb, Pavel Kuneša,b, Karolína Jankovičováa, Dana Vláškováb, Ctirad Andrýsa, Jan Krejseka

aCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Cardiac Surgery, Hradec Králové, Czech Republic

Received February 1, 2008
Accepted March 1, 2008


1. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD: Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann thorac Surg 2000; 69:1198–2004. <>
2. Czura AW, Czura ChJ. CD38 and CD157: Biological observations to clinical therapeutic targets. Mol Med 2006; 12(11–12):309–11. <> <PubMed>
3. Fernandez JE, Deaglio S, Donati D et al. Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeostatic Agents 1998; 12:81–91.
4. Franke A, Lante W, Fackeldey V et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardio-thoracic Surgery 2005; 28:569–75. <>
5. Goding JW, Howard MC. Ecto-enzymes of lymphoid cells. Immunol Rev 1998; 161:5–10. <>
6. Howard M, Grimaldi JC, Bazan JF et al. Formation and hydrolysis of cyclic ADPribose catalyzed by lymphocyte antigen CD38. Science 1993; 262:1056–9. <>
7. Kim UH, Kim JS, Han MK, Park BH, Kim HR. Purification and characterization of NAD glycohydrolase from rabbit erythrocytes. Arch Biochem Biophys 1993; 305:147–52. <>
8. Koláčková M, Jankovičová K, Trojáčková Kudlová M et al. The effect of cardiac surgery on peripheral blood lymphocyte populations. Acta Med (submitted).
9. Koláčková M, Kudlová M, Kuneš P et al. Early expression of FcγRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte antiinflammatory scavenger CD163 receptor in “on-pump” patients. Med Inflam 2007 (in press).
10. Krejsek J, Kuneš P, Koláčková M et al. The number of Toll-like receptor 2 and 4 expressing immune cells is changed during cardiac surgical operation. Scand J Clin Lab Invest (submitted).
11. Kudlová M, Koláčková M, Kuneš P et al. Expression of an activated form of integrin β2 chain CD18 in cardiac surgical operations. Acta Med 2007; 50(3): 187–193.
12. Kunes P, Lonsky V, Mandak J et al. The inflammatory response in cardiac surgery. An up-to-date overview with the emphasis on the role of heat shock proteins (HSPs) 60 and 70. Acta Med 2007; 50(2):93–99.
13. Kunes P, Lonsky V, Mandak J, Kolackova, M., Andrys, C., Kudlova, M., Krejsek, J. The long pentraxin 3 in cardiac surgery: distinct responses in “on-pump” and “off-pump” patients. Scand Cardiovasc J 2007; 41(3):171–9. <>
14. Lee HCh. Structure and enzymatic functions of human CD38. Mol Med 2006; 12(11–12):317–23.
15. Malavasi F, Deaglio S, Ferrero E et al. CD38 and CD157 as receptors of the immune systém: a bridge between innate and adaptive immunity. Mol Med 2006; 12(11–12):334–41. <>
16. Montserrat E. New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program 2006; 279–84. <>
17. Morabito F, Damle RN, Deaglio S, Keating M, Ferrarini M, Chiorazzi N. The CD38 ectoenzyme family: advances in basic science and clinical practice. Mol Med 2006; 12(12–12):342–4. <> <PubMed>
18. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardio-thoracic Surgery 2002; 21:232–44. <>
19. Pfister M, Ogilvie A, da Silva ChP, Grahnert A, Guse AH, Hauschildt S. NAD degradation and regulation of CD38 expression by human monocytes/macrophages. Eur J Biochem 2001; 268:5601–8. <>
20. Sanchez SP, Randall TD, Lund FE. Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity. Microbes Infect 2003; 5:49–58. <>
21. Stevenson GT. CD38 as a therapeutic target. Mol Med 2006; 12(11–12):345–6.
22. Viegas MS, do Carmo A, Silva T et al. CD38 plays a role in effective containment of mycobacteria within granulomata and polarization of Th1 immune responses against Mycobacterium avium. Microbes Infect 2007; 9:847–54. <>
23. Wehlin L, Vedin J, Vaage J, Lundahl J. Peripheral blood monocyte activation during coronary artery bypass grafting with or without cardiopulmonary bypass. Scand Cardiovasc J 2005; 39:78–86. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal